After the unprecedented times of COVID-19 lock-down that affected the entire world, the Mobilise-D members are now in a position to come back safely and restart their research in clinical settings. COVID-19 times are not over yet, and therefore they are taking all necessary precautions to prevent any potential risk for the team and study participants. This includes fewer interactions before entering the building, fever measurements, face masks being worn at all times, and thorough cleaning of contact surfaces and equipment before and after every participant. In addition, national guidelines are checked daily to keep their participants informed about current rules and regulations.
Mobilise-D centres involved in the data collections have been given green light to go back to their laboratories to refresh and retest protocols, and test the use of tools, novel sensors and software needed for collecting the data. Everything is now well prepared, and the team is delighted to be able to welcome participants to start data collection in August in Germany (Kiel and Stuttgart), United Kingdom (Newcastle and Sheffield), and in September in Israel (Tel Aviv).
They invite people with Parkinson’s disease, Multiple Sclerosis, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Proximal Femoral Fracture and healthy adults to participate in the technical validation study to contribute with crucial information about their mobility. To quantify their gait and walking behaviour, participants will be assessed wearing sensors in the laboratory under scripted and semi-controlled protocols, and in their real-world daily life.